Stockscreener 앱 받기
71.21
0.21%
-0.1525
전일 마감가:
$71.36
열려 있는:
$71.08
하루 거래량:
51,222
Relative Volume:
0.06
시가총액:
$12.31B
수익:
$8.31B
순이익/손실:
$379.00M
주가수익비율:
32.97
EPS:
2.16
순현금흐름:
$385.00M
1주 성능:
-4.74%
1개월 성능:
-8.58%
6개월 성능:
-3.85%
1년 성능:
+22.65%
1일 변동 폭
$71.08
$71.70
1주일 범위
$71.08
$74.76
52주 변동 폭
$54.26
$85.92
Solventum Corp Stock (SOLV) Company Profile
명칭
Solventum Corp
전화
651-733-1110
주소
C/O 3M COMPANY, ST. PAUL
SOLV을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SOLV
Solventum Corp
|
71.15 | 12.63B | 8.31B | 379.00M | 385.00M | 2.16 |
|
ISRG
Intuitive Surgical Inc
|
478.49 | 179.42B | 9.15B | 2.61B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
176.34 | 52.03B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
86.57 | 44.11B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
272.36 | 40.68B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
237.31 | 17.92B | 2.90B | 467.20M | 306.90M | 6.37 |
Solventum Corp Stock (SOLV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-15 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2025-07-01 | 업그레이드 | Argus | Hold → Buy |
| 2025-06-06 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2025-05-19 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2024-12-04 | 개시 | Mizuho | Neutral |
| 2024-10-08 | 개시 | Stifel | Buy |
| 2024-10-07 | 개시 | Piper Sandler | Neutral |
| 2024-09-26 | 개시 | Wolfe Research | Peer Perform |
| 2024-09-05 | 개시 | BTIG Research | Neutral |
| 2024-06-24 | 개시 | Argus | Hold |
| 2024-05-30 | 개시 | Goldman | Sell |
| 2024-05-10 | 개시 | BofA Securities | Neutral |
| 2024-04-10 | 개시 | Morgan Stanley | Equal-Weight |
| 2024-04-08 | 개시 | Wells Fargo | Equal Weight |
| 2024-04-02 | 개시 | Edward Jones | Hold |
모두보기
Solventum Corp 주식(SOLV)의 최신 뉴스
11 Best Medical Stocks to Buy According to Analysts - Insider Monkey
Stock Analysis | Solventum OutlookTechnical Weakness and Analyst Disagreement Cloud Near-Term Prospects - AInvest
Building trade automation scripts for Solventum CorporationReal Trader Watchlist of Hot Stocks Released - metal.it
Why Solventum Corporation stock attracts strong analyst attentionDaily Growth Stock Pick Reports Show Bullish Signals - metal.it
Advanced Wound Care Market to Hit $19.32 Billion by 2030 – What’s Fueling the Surge? | MarketsandMarkets™. - GlobeNewswire Inc.
What makes Solventum Corporation stock price move sharplyTarget Return Focused Trade Insights Shared - beatles.ru
What are the latest earnings results for Solventum CorporationOutstanding risk-reward balance - jammulinksnews.com
Is it the right time to buy Solventum Corporation stockBuild wealth with reliable stock picks - jammulinksnews.com
How many analysts rate Solventum Corporation as a “Buy”Discover high-impact stocks for growth - jammulinksnews.com
When is Solventum Corporation stock expected to show significant growthTrack high-yield stocks before they peak - jammulinksnews.com
Assessing the Strategic and Financial Implications of 3M's Spin-Off of Solventum - AInvest
3M Company: Adjusting to Solventum Spinoff and MMM Stock Performance - AInvest
3M Company: Still Adjusting To Spinoff Of Solventum (NYSE:MMM) - Seeking Alpha
What are Solventum Corporation company’s key revenue driversExceptional return forecasts - jammulinksnews.com
What to Expect From Solventum's Q2 2025 Earnings Report - MSN
Solventum Corporation Stock Analysis and ForecastConsistently high yield - PrintWeekIndia
Solventum Corporation's Anticipated Q2 2025 Earnings ReleaseNews and Statistics - IndexBox
What To Expect From Solventum's Q2 2025 Earnings Report - Barchart.com
Solventum to Report Second Quarter Fiscal 2025 Earnings on August 7, 2025 - StreetInsider
Lobbying Update: $60,000 of SOLVENTUM lobbying was just disclosed - Nasdaq
What analysts say about Solventum Corporation stockExtraordinary market timing - jammulinksnews.com
Solventum: Appealing Again (NYSE:SOLV) - Seeking Alpha
Is Solventum Corporation a good long term investmentExceptional growth trajectory - jammulinksnews.com
What drives Solventum Corporation stock priceOutstanding trading profits - jammulinksnews.com
Steris, Solventum upgraded, RxSight downgraded in Morgan Stanley's MedTech review - MSN
As more Minnesota companies rethink remote work, Solventum and others hold the line on flexibility - MSN
Earnings Alert: Solventum Sets Q2 2025 Report Date, Management to Discuss Future Outlook - Stock Titan
Steris, Solventum stocks upgraded at Morgan Stanley (STE:NYSE) - Seeking Alpha
Morgan Stanley upgrades Solventum stock rating to Overweight on margin potential By Investing.com - Investing.com South Africa
Morgan Stanley upgrades Solventum stock rating to Overweight on margin potential - Investing.com India
Morgan Stanley Upgrades Solventum to Overweight From Equalweight, Adjusts PT to $103 From $80 - MarketScreener
Thermo Fisher Wins EU Approval for Acquisition of Solventum's Filtration Business - MarketScreener
European Commission OKs Thermo Fisher's Purchase of Solventum's Purification, Filtration Arm - MarketScreener
Solventum Corp (SOLV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.46%
0.41%
자본화:
|
볼륨(24시간):